ImmunoPET: Antibody-Based PET Imaging in Solid Tumors

Area of Science:

• Oncology
• Radiochemistry
• Molecular Imaging

Background:

• Immuno-positron emission tomography (immunoPET) merges PET sensitivity with antibody targeting for cancer detection.
• While promising, clinical translation of immunoPET tracers faces challenges like slow kinetics and organ uptake.

Purpose of the Study:

• To review the fundamental components of immunoPET imaging.
• To explore the successes and challenges of current immunoPET tracers in solid tumors.
• To discuss ongoing developments in radioimmunotracer technology.

Main Methods:

• Literature review of immunoPET techniques and radioimmunotracers.
• Analysis of clinical translation status and limitations of existing tracers.
• Exploration of novel tracer development strategies.

Main Results:

• Several radioimmunotracers show potential for targeting various solid tumors.
• Key limitations include suboptimal tracer kinetics, lymphoid organ uptake, and intratumoral heterogeneity.
• Ongoing research focuses on overcoming these drawbacks for improved clinical utility.

Conclusions:

• ImmunoPET is a powerful tool for molecular imaging in oncology.
• Further development of radioimmunotracers is crucial for broader clinical application.
• Addressing current limitations will enhance the diagnostic and therapeutic potential of immunoPET.